No Data
No Data
No Data
No Data
No Data
Disa Unit Completes Trial Rollout of Eye Screening Device at Singapore Public Hospital; Shares Balloon 100%
Digital Life Line, a subsidiary of Disa's (SGX:532) wholly-owned DiSa Digital Safety, completed the first trial rollout of a medical device for eye screening in a major public hospital in Singapore, a
MT NewswiresApr 8 02:56 ET
DISA Shrinks Loss in Fiscal First Half
DISA (SGX:532) saw a 38.2% decline in attributable loss for the six months ended Dec. 31, 2023, to SG$686,000 from SG$1.1 million during the year-ago period. Loss per share remained consistent at SG$0
MT NewswiresFeb 13 04:48 ET
DiSa Unit Awarded European Quality Certification Mark for COVID-19 ART Kit
04:31 AM EDT, 05/24/2022 (MT Newswires) -- DiSa (SGX:532) said its its step down subsidiary Digital Life Line has been awarded CE-IVD (In-Vitro Diagnostic) mark for its Pasport Gold Sars-CoV-2 ART kit
MT NewswiresMay 24, 2022 04:32 ET
DISA Grants 10 Million Share Options Under Employee Share Option Scheme; Shares Surge 14%
12:59 AM EST, 01/13/2022 (MT Newswires) -- DISA (SGX:532) granted 10 million share options on Thursday under its employee share option scheme 2021, according to a same-day bourse disclosure. The opti
MT NewswiresJan 13, 2022 01:00 ET
Singapore Shares End Higher; DISA Balloons 100% on Plans to Commercialize Saliva-Based COVID-19 Test Kits
04:34 AM EST, 12/09/2021 (MT Newswires) -- Singapore's Straits Times Index returned to positive territory on Thursday following a strong lead from Wall Street, amid news that the Pfizer-BioNTech's CO
MT NewswiresDec 10, 2021 04:12 ET
DISA Unit to Commercialise New Saliva-Based COVID-19 Antigen Rapid Test Kits; Shares Balloon 50%
03:08 AM EST, 12/09/2021 (MT Newswires) -- DISA (SGX:532), via its step down subsidiary Digital Life Line, signed an agreement for the use of a new saliva-based COVID-19 antigen rapid test technology
MT NewswiresDec 10, 2021 03:42 ET
No Data
No Data